North American Milestones:

Virbac begins operations in the US - 1987

Acquires Allerderm®, the leading veterinary dermatology company - 1987

Introduces Preventic®, the benchmark in tick protection -1992

Patents Spherulites®, a unique technological breakthrough in the world of dermatology - 1998

Launches IVERHART PLUS®, the low-cost leader in heartworm prevention - 2001

Launches Genesis®, the first FDA-approved triamcinolone spray - 2002

Acquires Soloxine®, the Gold Standard in canine hypothyroid treatment -2003

Launches C.E.T.® HEXtra™, the first chlorhexidine dental chew - 2003

Relaunches Clintabs®, the only clindamycin in easy tablet form - 2004

Introduces IVERHART MAX™, the most complete FDA-approved heartworm preventive -2006

Launches Glycotechnology a proprietary formulation that prevents pathogens from attaching to skin - 2007

To Contact Virbac Directly:
Call: 1-800-338-3659

or Write:
3200 Meacham Blvd.
Fort Worth, Texas 76137





THE VIRBAC GROUP